Long

20-150% Profits Possible on SEEL Therapeutics

Zaktualizowano
My favorite new indie stock, Seelos Therapeutics, was recently upgraded from a price target of $4.70 to a whopping $15.
For this to happen, it may have to beat some bears (in SPY) and sharks (in short interest).
Short interest in the stock is down, with most shares not available to short. This is positive and bullish for shorter term.

The stock market looks to continue its rally, with minor downs, as usual, until further notice.
Biden's Infrastructure Plan may continue to stimulate the market to amazing new highs.

I may invest in this on Monday. I really need to make some $$ for food, rent, and my beloved kitten.

If it follows DLPN (Dolphin Entertainment), it may even beat its updated price target! DLPN was a rocket ship this year! Everyone go out and see some seals!
News had it that the Great White Sharks of Cape Town have disappeared this year!

Enough synchronicities, this is an ethical company that works on healing chronic diseases.

Resources:
stockinvest.us/stock/SEEL
stocktwits.com/symbol/SEEL
finance.yahoo.com/quote/SEEL?p=SEEL&.tsrc=fin-srch
nasdaq.com/market-activity/stocks/seel/news-headlines
seekingalpha.com/symbol/SEEL/ratings/quant-ratings?s=seel
investorshub.advfn.com/Seelos-Therapeutics-Inc-SEEL-4393/
seelostherapeutics.com/

#mayweallgetrichtogether

Uwaga
study below starts with $33,000.
Uwaga
With the market sell-off today, down to $4.65-80.
Beyond Technical AnalysisFundamental AnalysishealthcarestocksmedicalstockspennystocksprofitsecretsprofitsoverwagesseeltherapeuticsTrend Analysis

Wyłączenie odpowiedzialności